Optimal Traditional Chinese Medicine Formulas in Treating Ulcerative Colitis: Choose One or Take It All?

Overview

Journal World J Clin Cases

Publisher Baishideng Publishing Group

Specialty General Medicine

Date 2024 Nov 18

PMID 39554899

Authors

Yan Zeng

Jun-Wen Zhang

Jian Yang

Affiliations

Soon will be listed here.

Abstract

Ulcerative colitis (UC) is a chronic inflammatory bowel disease that presents significant treatment challenges due to its complexity, especially in terms of the various side effects that traditional medications may bring during the chronic course of the disease. Traditional Chinese medicine (TCM) has emerged as a promising complementary therapy for UC. Based on the latest research, our editorial explored the current issues and potential essential research directions for TCM in treating UC. We anticipate that future high-quality research will pave the way for the optimization of TCM formulas for UC and their broader global application.

References

Xie Q, Li H, Ma R, Ren M, Li Y, Li J . Effect of Coptis chinensis franch and Magnolia officinalis on intestinal flora and intestinal barrier in a TNBS-induced ulcerative colitis rats model. Phytomedicine. 2022; 97:153927. DOI: 10.1016/j.phymed.2022.153927. View

Zhao Z, Hu Y, Liang Z, Yuen J, Jiang Z, Leung K . Authentication is fundamental for standardization of Chinese medicines. Planta Med. 2006; 72(10):865-74. DOI: 10.1055/s-2006-947209. View

Zhao Z, Liang Z, Chan K, Lu G, Lee E, Chen H . A unique issue in the standardization of Chinese materia medica: processing. Planta Med. 2010; 76(17):1975-86. DOI: 10.1055/s-0030-1250522. View

Zheng S, Xue T, Wang B, Guo H, Liu Q . Chinese Medicine in the Treatment of Ulcerative Colitis: The Mechanisms of Signaling Pathway Regulations. Am J Chin Med. 2022; 50(7):1781-1798. DOI: 10.1142/S0192415X22500756. View

Cai Y, Zhang L, Zhang Y, Lu R . Plant-Derived Exosomes as a Drug-Delivery Approach for the Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer. Pharmaceutics. 2022; 14(4). PMC: 9029273. DOI: 10.3390/pharmaceutics14040822. View

Rahman S, Haq F, Ali A, Khan M, Shah S, Adhikhari A . Combining untargeted and targeted metabolomics approaches for the standardization of polyherbal formulations through UPLC-MS/MS. Metabolomics. 2019; 15(9):116. DOI: 10.1007/s11306-019-1582-6. View

Wang M, Fu R, Xu D, Chen Y, Yue S, Zhang S . Traditional Chinese Medicine: A promising strategy to regulate the imbalance of bacterial flora, impaired intestinal barrier and immune function attributed to ulcerative colitis through intestinal microecology. J Ethnopharmacol. 2023; 318(Pt A):116879. DOI: 10.1016/j.jep.2023.116879. View

Ransford R, Langman M . Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines. Gut. 2002; 51(4):536-9. PMC: 1773410. DOI: 10.1136/gut.51.4.536. View

Zhao Z, Dong Y, Jiang X, Wang J, Qin W, Liu Z . Five commonly used traditional Chinese medicine formulas in the treatment of ulcerative colitis: A network meta-analysis. World J Clin Cases. 2024; 12(22):5067-5082. PMC: 11238807. DOI: 10.12998/wjcc.v12.i22.5067. View

10.

Gu X, Miao Z, Wang Y, Yang Y, Yang T, Xu Y . New Baitouweng decoction combined with fecal microbiota transplantation alleviates DSS-induced colitis in rats by regulating gut microbiota metabolic homeostasis and the STAT3/NF-κB signaling pathway. BMC Complement Med Ther. 2022; 22(1):307. PMC: 9686021. DOI: 10.1186/s12906-022-03766-z. View

11.

Wang D, Wang Q, Wang Y, Li T, Tian M . Effects of acupuncture and moxibustion on ulcerative colitis: An overview of systematic reviews. Heliyon. 2024; 10(6):e27524. PMC: 10951544. DOI: 10.1016/j.heliyon.2024.e27524. View

12.

Zhang H, Sun Y, Fan M, Zhang Y, Liang Z, Zhang L . Prevention effect of total ginsenosides and ginseng extract from Panax ginseng on cyclophosphamide-induced immunosuppression in mice. Phytother Res. 2023; 37(8):3583-3601. DOI: 10.1002/ptr.7836. View

13.

Fernandez M, Nazar F, Moine L, Jaime C, Kembro J, Correa S . Network Analysis of Inflammatory Bowel Disease Research: Towards the Interactome. J Crohns Colitis. 2022; 16(11):1651-1662. DOI: 10.1093/ecco-jcc/jjac059. View

14.

Pan S, Wang C, Hu Z, Zhang M, Pan Z, Zhou R . Baitouweng decoction repairs the intestinal barrier in DSS-induced colitis mice via regulation of AMPK/mTOR-mediated autophagy. J Ethnopharmacol. 2023; 318(Pt A):116888. DOI: 10.1016/j.jep.2023.116888. View

15.

Murray A, Nguyen T, Parker C, Feagan B, MacDonald J . Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis. Cochrane Database Syst Rev. 2020; 8:CD000543. PMC: 8189994. DOI: 10.1002/14651858.CD000543.pub5. View

16.

Moss J, Parry C, Holt R, McWilliam S . 5-ASA induced interstitial nephritis in patients with inflammatory bowel disease: a systematic review. Eur J Med Res. 2022; 27(1):61. PMC: 9052675. DOI: 10.1186/s40001-022-00687-y. View

17.

Wu B . Acute moderate to severe ulcerative colitis treated by traditional Chinese medicine: A case report. World J Clin Cases. 2023; 10(36):13356-13363. PMC: 9851011. DOI: 10.12998/wjcc.v10.i36.13356. View

18.

Li C, Dong N, Wu B, Mo Z, Xie J, Lu Q . Dihydroberberine, an isoquinoline alkaloid, exhibits protective effect against dextran sulfate sodium-induced ulcerative colitis in mice. Phytomedicine. 2021; 90:153631. DOI: 10.1016/j.phymed.2021.153631. View

19.

Wang Y, Hao Y, Yuan L, Tian H, Sun X, Zhang Y . Ferroptosis: a new mechanism of traditional Chinese medicine for treating ulcerative colitis. Front Pharmacol. 2024; 15:1379058. PMC: 11184165. DOI: 10.3389/fphar.2024.1379058. View

20.

Gao C, Liu L, Zhou Y, Bian Z, Wang S, Wang Y . Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease. Chin Med. 2019; 14:23. PMC: 6580650. DOI: 10.1186/s13020-019-0245-x. View